Search results for "EYS"

showing 10 items of 4293 documents

Stress-related psychosocial factors at work, fatigue, and risky driving behavior in bus rapid transport (BRT) drivers

2016

Abstract Introduction There is consistent scientific evidence that professional drivers constitute an occupational group that is highly exposed to work related stressors. Furthermore, several recent studies associate work stress and fatigue with unsafe and counterproductive work behaviors. This study examines the association between stress-related work conditions of Bus Rapid Transport (BRT) drivers and risky driving behaviors; and examines whether fatigue is a mechanism that mediates the association between the two. Method A sample of 524 male Bus Rapid Transit (BRT) operators were drawn from four transport companies in Bogota, Colombia. The participants answered a survey which included an…

AdultMaleAutomobile DrivingPoison controlWorking conditionsHuman Factors and ErgonomicsColombiaStructural equation modelingOccupational safety and health03 medical and health sciencesSocial supportRisk-Taking0302 clinical medicineJob stressSurveys and Questionnaires0502 economics and businessHumansSafety Risk Reliability and QualityFatigueOccupational HealthBus rapid transitRiesgos laborales050210 logistics & transportationJob strainFatiga05 social sciencesPublic Health Environmental and Occupational HealthSocial SupportHuman factors and ergonomics030210 environmental & occupational healthProfessional driversOccupational DiseasesMotor VehiclesAccidentes de tránsitoFemaleSafetyPsychologySocial psychologyPsychosocialStress Psychological
researchProduct

Anxiety and facial self-contacts: possible impact on COVID-19 transmission in dental practice

2021

Abstract Background The purpose was to analyse the associations between dental and trait anxiety, fear of COVID-19 and the duration and frequency of spontaneous hand-to-face contact (self-contact). Methods A cross-sectional design was carried out with 128 adult patients from four dental clinics in Madrid, during the confinement, from March 15 to May 15. The patients’ movements in the waiting room were monitored with Microsoft Kinect Software, also completed the Trait anxiety subscale of the STAI, the COVID-19 Fear and the S-DAI questionnaire. Results Associations were observed between the duration and frequency of facial, mask and eye contact with trait anxiety and dental fear was determine…

AdultMaleBiopsychosocial modelCross-sectional studyPopulationEye contactDental fearAnxietyDental fear03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesDental AnxietymedicineHumansDents030212 general & internal medicineeducationGeneral Dentistryeducation.field_of_studySARS-CoV-2business.industryHigh riskResearchIncidence (epidemiology)COVID-19RK1-715030206 dentistrymedicine.diseaseAnsietatstomatognathic diseasesCross-Sectional StudiesTouchDentistryOral and maxillofacial surgeryAnxietyFemalemedicine.symptombusinessClinical psychologyBMC Oral Health
researchProduct

Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders

2010

Abstract Objective To assess the sensitivity and specificity of two self-report instruments for detection of bipolarity in a sample of Argentinean patients. Method Spanish versions of the MDQ and the BSDS were administered over four months at 11 sites in Argentina. Diagnoses were made using DSM-IV criteria and the MINI. The study sample consisted of patients diagnosed with Bipolar Disorder (BD) Types I, II, or NOS. BDNOS diagnoses were made using extended guidelines for bipolar spectrum symptoms. Unipolar patients were used as a control group. Of 493 patients screened, 354 completed evaluation by MDQ and MINI, and 363 by BSDS and MINI. Results Specificity of MDQ was 0.97 and BSDS was 0.81. …

AdultMaleBipolar DisorderAdolescentPsychometricsPsychometricsArgentinaSensitivity and SpecificityPrevalence of mental disordersSurveys and QuestionnairesOutpatientsmental disordersmedicineHumansBipolar disorderMedical diagnosisAgedPsychiatric Status Rating ScalesBipolar spectrum diagnostic scaleMood DisordersNot Otherwise SpecifiedMood Disorder QuestionnaireMiddle AgedWeights and Measuresmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyMood disordersFemalePsychologyClinical psychologyJournal of Affective Disorders
researchProduct

Physician attitudes to blood pressure control

2011

OBJECTIVES: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) physician survey aimed to qualify the key challenges that physicians face when trying to get patients to blood pressure (BP) goal. METHODS: The SHARE survey was open to physicians involved in the treatment of patients with hypertension, was anonymous, and was designed to take 15 min to complete. The survey included 45 questions covering physicians' demographic information, views on the BP targets recommended by the European Society of Hypertension-European Society of Cardiology guidelines, opinions on acceptable levels of BP control, and perceptions about the challenges associated with getting patients to BP …

AdultMaleBlood pressure controlHealth Knowledge Attitudes Practicemedicine.medical_specialtyBiomedical ResearchAttitude of Health PersonnelPhysiologyElevated bpMEDLINEBlood PressureRisk AssessmentPhysiciansSurveys and QuestionnairesInternal MedicineHumansMedicinePractice Patterns Physicians'Antihypertensive Agentsbusiness.industryGuideline adherenceGuidelineAwarenessMiddle AgedHealth SurveysEuropeBlood pressureCardiovascular DiseasesPhysician surveyFamily medicineHypertensionFemaleGuideline AdherenceCardiology and Cardiovascular MedicinebusinessRisk assessmentJournal of Hypertension
researchProduct

Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study

2012

SummaryBackgroundStudies with inhaled corticosteroids (ICS) in smoking asthmatics have mostly shown poorer treatment responses than in non-smoking asthmatics.MethodsEuroSMART, an open, randomised, 6-month study, compared budesonide/formoterol (Symbicort ® Turbuhaler®)hhNeither the Symbicort SMART posology nor the dry powder formulation, Turbuhaler, is currently approved in the US. maintenance and reliever therapy (Symbicort SMART®) at two maintenance doses of budesonide/formoterol (160/4.5 μg), 1 × 2 and 2 × 2, in patients with asthma who were symptomatic despite treatment with ICS ± long-acting β2-agonists. The 8424 randomised patients included 886 smokers (11%; aged <40 years or with a sm…

AdultMaleBudesonidePulmonary and Respiratory MedicineSymbicort SMARTmedicine.medical_specialtyPeak Expiratory Flow RatePropensity-matched controlsDrug Administration Schedulelaw.inventionACQ-5Budesonide/formoterol maintenance and reliever therapyPharmacotherapyRandomized controlled triallawFormoterol FumarateSurveys and QuestionnairesInternal medicineAdministration InhalationmedicineHumansAnti-Asthmatic AgentsDosingBudesonideAsthmaSmokersDose-Response Relationship Drugbusiness.industrySmokingmedicine.diseaseAsthmaBronchodilator Agentsrespiratory tract diseasesTreatment OutcomeBudesonide/formoterolEthanolaminesAnesthesiaDisease ProgressionDrug Therapy CombinationFemaleFormoterol FumarateFormoterolbusinessmedicine.drugRespiratory Medicine
researchProduct

New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey

2018

BACKGROUND: In Italy, the National Register of Congenital Coagulopathies (NRCC) collects epidemiological and therapeutic data from patients affected by haemophilia A (HA), haemophilia B (HB), von Willebrand’s disease (vWD) and other rare coagulation disorders. Here we present data from the 2016 annual survey. MATERIALS AND METHODS: Data are provided by the Italian Haemophilia Centres, on a voluntary basis. Information flows from every Centre to a web-based platform of the Italian Association of Haemophilia Centres, shared with the Italian National Institute of Health, in accordance with current privacy laws. Patients are classified by diagnosis, disease severity, age, gender and treatment-r…

AdultMaleCanadaAdolescentAdolescent Adult Aged Blood Coagulation Factors Canada Child Coagulation Protein Disorders Factor IX Factor VIII Female France HIV Infections Hemophilia A Hemophilia B Hepatitis CHumans Infant Infant Newborn Italy Male Middle Aged Prevalence Registries Surveys and Questionnaires United Kingdom von Willebrand DiseasesHIV InfectionsCoagulation Protein DisordersHemophilia AHemophilia BFactor IXhemic and lymphatic diseasesSurveys and QuestionnairesPrevalenceHumansRegistriesChildAgedFactor VIIIInfant NewbornInfantMiddle AgedHepatitis CBlood Coagulation FactorsUnited Kingdomvon Willebrand DiseasesItalyChild PreschoolFemaleOriginal ArticleFrance
researchProduct

Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: first results from a patient survey by the German Study Group for M…

2021

AdultMaleCancer Researchmedicine.medical_specialty2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEGermanYoung AdultGermanySurveys and QuestionnairesInternal medicineCorrespondencemedicineHumansAgedAged 80 and overMyeloproliferative DisordersSARS-CoV-2business.industryCOVID-19HematologyMiddle AgedPrognosisTelemedicinelanguage.human_languageOncologylanguageFemalePatient surveybusinessFollow-Up StudiesLeukemia Research
researchProduct

FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.

2016

The chemoimmunotherapy FCR (fludarabine and cyclophosphamide with rituximab) is the standard first-line treatment for physically fit chronic lymphocytic leukemia (CLL) patients. To assess the risks and benefits, we investigated health-related quality of life (HRQOL). 817 untreated CLL patients received either FC or FCR within the GCLLSG CLL8 trial. The European Organization for Research and Treatment of Cancer Quality of life Questionnaire C30 was sent to all patients at baseline, after 3, 6, and 12 months and then yearly as follow-up. A total of 769 (94%) of 817 patients completed at least one questionnaire. Comparing HRQOL of CLL patients with the general German population, CLL patients' …

AdultMaleCancer Researchmedicine.medical_specialtyCyclophosphamideChronic lymphocytic leukemiaMedication Adherence03 medical and health sciences0302 clinical medicineSex FactorsQuality of lifeChemoimmunotherapyhemic and lymphatic diseasesInternal medicineSurveys and QuestionnairesAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansCyclophosphamideAgedAged 80 and overbusiness.industryCase-control studyHematologyMiddle Agedmedicine.diseaseLeukemia Lymphocytic Chronic B-CellhumanitiesFludarabineLeukemiaTreatment OutcomeOncology030220 oncology & carcinogenesisCase-Control StudiesPhysical therapyQuality of LifeRituximabFemalebusinessRituximabVidarabine030215 immunologymedicine.drugFollow-Up StudiesLeukemialymphoma
researchProduct

The EORTC module for quality of life in patients with thyroid cancer: phase III

2017

The purpose of the study was to pilot-test a questionnaire measuring health-related quality of life (QoL) in thyroid cancer patients to be used with the European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire EORTC QLQ-C30. A provisional questionnaire with 47 items was administered to patients treated for thyroid cancer within the last 2 years. Patients were interviewed about time and help needed to complete the questionnaire, and whether they found the items understandable, confusing or annoying. Items were kept in the questionnaire if they fulfilled pre-defined criteria: relevant to the patients, easy to understand, not confusing, few missing values, neither …

AdultMaleCancer Researchmedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismPilot ProjectsIodine Radioisotopes03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeInternal medicineSurveys and QuestionnairesMedicineHumansIn patientThyroid NeoplasmsThyroid cancerProtein Kinase InhibitorsAgedAged 80 and overbusiness.industryCancerMiddle Agedmedicine.diseasehumanitiesSurgeryOncology030220 oncology & carcinogenesisQuality of LifeFemalebusinessRare cancers Radboud Institute for Health Sciences [Radboudumc 9]
researchProduct

How do international gastric cancer prevention guidelines influence clinical practice globally?

2020

Clinical guidelines recommend particular approaches, including 'screen-and-treat' strategy for Helicobacter pylori, to prevent gastric cancer. However, little of this is implemented in clinical practice. The aim of the study was to identify barriers to implementation of international guidelines. A web-based questionnaire distributed globally to specialists in the field. Altogether 886 responses from 75 countries were received. Of the responders, 570 (64%) were men of mean age 47 years. There were 606 gastroenterologists and 65 epidemiologists among the responders. Altogether, 79.8% of the responders disagreed that the burden of gastric cancer is a diminishing problem. 'Screen-and-treat' str…

AdultMaleCancer Researchmedicine.medical_specialtyEpidemiologyPopulationMEDLINEHelicobacter Infections03 medical and health sciencesYoung Adult0302 clinical medicineSDG 3 - Good Health and Well-beingStomach NeoplasmsSurveys and QuestionnairesmedicineHumans030212 general & internal medicinePractice Patterns Physicians'educationEarly Detection of CancerAgedAged 80 and overeducation.field_of_studybiologyHelicobacter pyloribusiness.industryGastric cancer preventionUpper endoscopyPublic Health Environmental and Occupational HealthCancerInternational AgenciesHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationPrognosis3. Good healthClinical PracticeVaccinationSurvival RateOncology030220 oncology & carcinogenesisFamily medicinePractice Guidelines as Topic/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalebusinessEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
researchProduct